ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2020 American Transplant Congress

    Clinical Outcomes in Kidney Transplant Recipients Following Implementation of a Strategic Maintenance Reduction Protocol

    H. Perkins, K. Foster, N. Patel, H. Meadows, F. Bartlett, C. Perez, J. McGillicuddy, N. Pilch, M. Casey, M. A. Posadas-Salas, D. Taber

    Pharmacy, Medical University of South Carolina, Charleston, SC

    *Purpose: Post-transplant complications are commonly due to over-immunosuppression, particularly as it relates to infections. The purpose of this study was to assess clinical outcomes in…
  • 2020 American Transplant Congress

    T Cell Hyporesponsiveness in Kidney Transplant Recipients is Associated with Urinary Tract Infections and Age of Kidney Transplant: Implications for Allograft Nephropathy

    A. Assounga, S. Omarjee

    Dept of Nephrology, University of KwaZulu-Natal, Durban, South Africa

    *Purpose: Chronic allograft nephropathy is the main cause of kidney graft loss. With the use of potent immunosuppressive treatments, acute rejections are less and less…
  • 2020 American Transplant Congress

    The Incidence, Clinical Characteristics and Prophylactic Strategy of Invasive Fungal Infections in Lung Transplantation

    L. Zhao1, W. Chen1, L. Guo1, L. Jing1, C. Liang1, J. Chen1, C. Wang2

    1Department of Lung Transplantation, China-Japan Friendship Hospital, Beijing, China, 2China-Japan Friendship Hospital, Beijing, China

    *Purpose: Invasive Fungal infections in lung transplant recipients(LTR) were common and harmful, remaining a major cause of morbidity and mortality after lung transplantation. The incidence,…
  • 2020 American Transplant Congress

    Impact of Frailty on Early and Late Hospital Readmission after Kidney Transplantation

    H. Hendra1, B. Sandhu2, E. Frackiewicz2, G. Jones2, P. Masson2, R. Motallebzadeh3

    1Centre for Transplantation, Department of Renal Medicine, University College London & Royal Free London NHS Foundation Trust, London, United Kingdom, 2Royal Free Hospital, London, United Kingdom, 3Centre for Transplantation, University College London & Royal Free London NHS Foundation Trust, London, United Kingdom

    *Purpose: Currently there are no tools to predict outcomes after kidney transplantation (KTx). This study assesses whether frailty influences post-KTx complications. Understanding frailty and its…
  • 2020 American Transplant Congress

    Kidney Transplantation from HBsAg+ Living Donors to HBsAg- Recipients: A Propensity Score-Matched Study at a High-Volume Center in China

    X. Wang, J. Liu, T. Song, Y. Fan, Z. Huang, T. Lin

    Urology, West China Hospital, Chengdu, China

    *Purpose: Data on kidney transplantation (KTx) from hepatitis B surface antigen (HBsAg)+ donors to HBsAg- recipients [D(HBsAg+)/R(HBsAg-)] are limited. We aimed to report the outcomes…
  • 2020 American Transplant Congress

    Epidemiology of Invasive Fungal Infections in Heart Transplant Recipients

    A. Couture-Cossette1, A. Puing1, A. Multani2, O. Quintero1, A. K. Subramanian1, E. Henricksen3, R. Lee1, Y. Moayedi4, K. Khush5, J. J. Teuteberg5, D. Y. Ho1

    1Department of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, 2Department of Infectious Diseases, UCLA, Stanford, CA, 3Pharmacy, Stanford Healthtcare, Stanford, CA, 4Department of Cardiology, UHN, Toronto, ON, Canada, 5Division of Cardiology, Department of Medicine, Stanford University, Stanford, CA

    *Purpose: The incidence and epidemiology of invasive fungal infections (IFI) after heart transplantation (HTx) are influenced by changes in environmental exposures, immunosuppression, and prophylaxis practices.…
  • 2020 American Transplant Congress

    Differences in Alemtuzumab Dosing Does Not Affect Early Kidney Transplant Outcomes

    A. Pressley, R. Stratta, J. Rogers, A. Farney, G. Orlando, W. Doares, A. Reeves-Daniel, C. Jay

    Wake Forest Baptist Health, Winston-Salem, NC

    *Purpose: Alemtuzumab (Alem) is a widely used medication for induction therapy in kidney transplantation. However, there is limited evidence comparing outcomes with low versus high…
  • 2020 American Transplant Congress

    Impact of Organ Donor Infections on Kidney Transplant Recipient Outcomes

    M. Santarossa1, C. Muran2, S. Sanchez2, L. Heinrich2, J. Yoo3, F. Albarillo1, S. Akkina3, N. Clark1, G. Reid1

    1Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, 2Department of Pharmacy, Loyola University Medical Center, Maywood, IL, 3Department of Medicine, Division of Transplant Nephrology, Loyola University Medical Center, Maywood, IL

    *Purpose: Donor-derived infections can lead to significant morbidity and mortality in organ transplant recipients. There is variability by center on treatment of positive donor cultures…
  • 2020 American Transplant Congress

    Phage Therapy for Mycobacterium Abscessus (Mab) Infection after Lung Transplant (LT)

    W. Garner1, R. Dedrick2, C. Guerrero2, M. Morrell1, J. D'Cunha3, P. Sanchez1, G. Hatfull2, G. Haidar1

    1University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3Mayo Clinic Arizona, Phoenix, AZ

    *Purpose: LT recipients with Mab infections have poor outcomes. We describe a patient with refractory Mab infection treated with mycobacteriophage therapy.*Methods: A 56-year-old woman with…
  • 2020 American Transplant Congress

    Clinical Correlations Associated with Development of De Novo Donor-Specific Antibody in the First Year Following Kidney Transplant at a Single Center

    J. M. Zimmerer1, M. Basinger1, B. A. Ringwald1, R. Pelletier2, A. Rajab1, A. El-Hinnawi1, M. Abdel-Rasoul1, K. Washburn1, G. L. Bumgardner1

    1Ohio State University, Columbus, OH, 2Robert Wood Johnson Barnabas Health, New Brunswick, NJ

    *Purpose: The development of de novo donor-specific antibody (dnDSA) portends inferior long-term graft survival. This study investigates the short-term clinical correlations associated with dnDSA that…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences